Discover how BRCA1 protein's dual role in DNA repair and microtubule ubiquitination makes Taxol chemotherapy effective against cancer cells.
Discover how III-Tubulin protein makes cancer blood vessels resistant to chemotherapy and how new research is finding ways to overcome this resistance.
Explore the science behind tubulin-targeted cancer therapies, from established medications to cutting-edge compounds revolutionizing cancer treatment.
Discover how 6-bromoindirubin acetoxime (BiOX) modulates the blood-tumor barrier to enhance chemotherapy delivery in glioblastoma treatment.
Understanding how cytochrome P450 enzymes transform mitoxantrone into both therapeutic and toxic compounds in cancer treatment.
Discover why diffuse gastric cancer resists taxane chemotherapy through impaired drug binding mechanisms and emerging solutions.
Discover how gamma-tubules, the newly discovered cellular filaments, are revolutionizing cancer treatment by targeting tumors selectively while sparing healthy cells.
Exploring the revolutionary next-generation microtubule-targeting agents that are transforming cancer treatment paradigms.
Discover how Anisina, a first-in-class drug targeting cancer's cytoskeleton, enhances chemotherapy effectiveness by 20-fold in neuroblastoma and other resistant cancers.